Sagimet Biosciences Inc. Series A Common Stock (SGMT) — Working Capital to Net Assets Ratio
Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a Working Capital to Net Assets ratio of 100.0% as of March 2026. Working capital of $102.42 Million (current assets of $107.72 Million minus current liabilities of $5.30 Million) is measured against net assets of $102.46 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Sagimet Biosciences Inc. Series A Common (SGMT) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sagimet Biosciences Inc. Series A Common Stock Working Capital to Net Assets (2019–2025)
This chart shows how Sagimet Biosciences Inc. Series A Common Stock's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting working capital of $102.42 Million against net assets of $102.46 Million USD. See SGMT cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Sagimet Biosciences Inc. Series A Common Stock (2019–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sagimet Biosciences Inc. Series A Common Stock from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Sagimet Biosciences Inc. Series A Common market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.9% | $111.30 Million | $111.38 Million | $116.40 Million | $5.10 Million | ▲ +4.7 pp |
| 2024 | 95.2% | $148.32 Million | $155.81 Million | $152.77 Million | $4.45 Million | ▼ -4.7 pp |
| 2023 | 99.9% | $90.99 Million | $91.06 Million | $96.65 Million | $5.65 Million | ▲ +114.6 pp |
| 2022 | -14.7% | $27.51 Million | $-186.95 Million | $32.79 Million | $5.28 Million | ▲ +20.8 pp |
| 2021 | -35.5% | $56.22 Million | $-158.26 Million | $58.66 Million | $2.44 Million | ▲ +13.6 pp |
| 2020 | -49.2% | $66.83 Million | $-135.91 Million | $68.74 Million | $1.91 Million | ▼ -42.2 pp |
| 2019 | -7.0% | $8.74 Million | $-125.31 Million | $10.81 Million | $2.08 Million | — |